维普中文期刊产品整合服务
14篇 您的检索式:作者名="PAUL ND"
    题名 作者 年代 出处 被引量
1Lipid peroxidation abnormalities in hemodialyzed patients显示文摘 Sall ND Soni T 1993Nephron1993,64,:1
2Human embryonic stem cells as a model for nutritional programming:An evaluation显示文摘CINZIA A CHRIS ND PAUL B 2005Reproductive Toxicology2005,20,:1
3下肢截肢术后持续周围神经阻滞的作用:对幻肢综合征症状的影响显示文摘背景达90%的截肢者在肢体截肢术后会产生幻肢综合征(phantom limb syndroms,PLS)。尽管现在有很多不同的治疗方法,但没有一种是显著有效的。因此,我们评估了高浓度的局麻药在外周神经的持续输注对预防PLS的效果。方法在术前或术中给71例行下肢截肢术的患者放置一周围神经导管,通过弹力输注泵(非电子)在术中开始以5ml/h的速率持续输注0.5%罗哌卡因,并且持续到术后的第4—83天。在术后的第1天,第1、2、3、4周和第3、6、9、12月评估PLS。为了评估患者在接受罗哌卡因输注时PLS是否存在及其严重程度,在每次评估前中断6—12小时的给药(即直至肢体感觉的恢复)。幻肢痛和残肢痛的程度由5分级的VRS评分系统来评分,其中0分代表无疼痛,4分代表不能忍受的疼痛,而幻肢的感觉被记录为存在或者不存在。如果VRS评分大干1分或者有显著的幻肢感觉出现,罗哌卡因立即以5ml/h的速率重新开始输注。如果患者的VRS评分持续为0或1分并且无幻肢感觉达48小时,则输注完全停止并移除导管。结果局麻药的持续输注时间的中位数是30天(95%的可信区间,25-30天)。在术后第1天,73%的患者主诉有严重的或者不能忍受的疼痛(VRS评分大于2分)。但是,在12个月的评估期的最后患者“严重到不能忍受”的幻肢痛的发生率仅为3%。在第12个月末,患者VRS疼痛评分的百分比:84%的患者为0分,10%的患者为1分,3%的患者为2分,3%的患者为3分,没有患者为4分。但是,在12个月的评估期的最后仍有39%的患者有幻肢感觉。所有患者都能在家中应用这种弹力输注系统。结论术后予以0.5%的罗哌卡因于神经周的持续输注可能是下肢截肢术后治疗幻肢痛和幻肢感觉的有效方法。Battista Borghi, MD Marco D'Addabbo, MD Paul F. White, MD, PhD Pina Gallerani,RN Letizia Toccaceli, ND William Raffaeli, MD Andrea Tognu, MD Nicola Fabbri, MD and Mario Mercuri, MD 毛祖旻(译) 李士通(校) 2012麻醉与镇痛2012,8,3:1
4Optical grating coupler biosensors显示文摘Voros J Ramsden JJ Csucs G Szendro I De Paul SM Textor M Spencer ND 2002Biomaterials2002,23,:1
5Three-dimentional helical Computed Tommgraphy Cholangiography with minimum intensity projection in gallbladder carcinoma patients with obstructive jaundice:comparison with magnetic resonance cholangiography显示文摘Rao ND Gulati MS Paul SB 2005Journal of Gastroenterrology and Hepatology2005,20,2:1
6The dose rate of UVA treatment influences the cellular response of HaCaT keratino- cytes 显示文摘Shorrocks J Paul ND McMillan TJ 2008J Invest Dermatol2008,128,3:1
7Response differences and preferences for all-category-defined and end-defined likert formats 显示文摘Paul ND Mackie Bobo Richard AS 1984Edu Psyehol Meas1984,44,:1
8Primarypreventionof cardiovascular diseasewith atorvastatin in type 2 diabetesin the CollaborativeAtorvastatinDiabetes Study(CARDS):multicentre randomised placebo2controlled trial显示文摘Helen MC D John B Paul ND 0,,:1
9Ecological roles of solar UV radiation: towards an integrated approach 显示文摘Paul ND Gwynn-Jones D 2003Trends Ecol Evol2003,18,:1
10Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS):mul- ticentre randomised placebo-controlled trial显示文摘Helen MC D John B Paul ND 2004Lancet2004,64,4:1
11Discordance between bone turnover and bone loss:effects of aging and ovariectomy in the rat显示文摘PAUL AJ BALDO CK ALLANG ND 1999J Bone Miner Res1999,14,:1
12Three-dimensional helical computed tomography cholangiography with minimum intensity projection in gallbladder carcinoma patients with obstructive jaundice:comparison with magnetic resonance cholangiography and percutaneous transhepatic cholangiography显示文摘Rao ND Gulati MS Paul SB 2005J Gastroenterol and Hepatol2005,20,2:1
13Ecological roles of solar UV radiation:towards an integrated approach显示文摘PAUL ND GWYNN-JONES D 2003Trends in Ecology & Evolution2003,18,1:1
14The role of interactions between trophic levels in determining the effects of UV-B on terrestrial ecosystems 显示文摘Paul ND Rasanayagam S Moody SA et at 1997Plant Ecol1997,128,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费